T3	Effect 61 77	acute dermatitis
T4	Subject 0 15;35 47	Of 371 patients three (0.8%)
T6	Treatment 16 33	treated with 8MOP
T7	Population 3 6;35 47	371 three (0.8%)
T8	Drug 29 33	8MOP
T5	Adverse_event 48 57	developed
E1	Adverse_event:T5